Medicinal Products

Sagilia 1 mg tablete

Name Sagilia 1 mg tablete
Marketing Authorisation Number HR-H-184246775
Active Substance razagilintartarat
Composition svaka tableta sadrži 1 mg razagilina (u obliku razagilintartarata)
Pharmaceutical Form tableta
Manufacturer Medochemie Ltd., Limassol, Cipar
Marketing Authorisation Holder Medochemie Ltd., Constatinoupoleos Str. 1-10, Limassol, Cipar
Marketing Authorisation Date 11.03.2020
MA Period of Validity unlimited
Classification Number UP/I-530-09/20-02/17
Registration Number 381-12-01/38-20-03
Prescription Medicinal product subject to medical prescription
Type of prescription ponovljivi recept
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code N04BD02
Marketing status stavljeno u promet
Shortage status nema nestašice
SmPC download
PL download
Public Assessment Report download

Packaging

Back